CN Stock MarketDetailed Quotes
603707 Nanjing King-Friend Biochemical Pharmaceutical
- 12.19
- +0.40+3.39%
Market Closed Sep 4 15:00 CST
19.69BMarket Cap-48181P/E (TTM)
12.35High11.73Low96.28KlotVolume11.75Open11.79Pre Close116.91MTurnover0.60%Turnover RatioLossP/E (Static)1.62BShares16.3052wk High3.27P/B19.69BFloat Cap10.4552wk Low12.97Limit Up1.62BShs Float35.10Historical High10.61Limit Down5.26%Amplitude2.15Historical Low0.10Dividend TTM12.14Avg Price36.60KlotAsk0.82%Div YieldTTM100Lot Size58.28KlotBid
Nanjing King-Friend Biochemical Pharmaceutical Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -11.65%1.97B | -4.05%935.39M | 24.09%4.68B | 9.58%3.31B | 2.52%2.23B | -5.14%974.83M | 2.00%3.77B | 22.39%3.02B | 26.13%2.18B | 14.06%1.03B |
| Refunds of taxes and levies | -7.48%123.87M | -42.84%38.21M | 0.89%246.66M | -2.66%196.3M | -7.14%133.89M | 5.99%66.85M | 50.89%244.48M | 45.78%201.67M | 51.41%144.19M | 124.55%63.08M |
| Cash received relating to other operating activities | 127.27%56.3M | 553.63%19.71M | 65.02%102.13M | 6.03%74.46M | -19.34%24.77M | -89.21%3.01M | -59.91%61.89M | -47.39%70.23M | -0.25%30.71M | -12.08%27.95M |
| Cash inflows from operating activities | -9.98%2.15B | -4.92%993.31M | 23.32%5.03B | 8.76%3.58B | 1.64%2.39B | -6.61%1.04B | 1.60%4.08B | 20.18%3.3B | 26.99%2.35B | 16.43%1.12B |
| Goods services cash paid | -21.16%937.81M | -33.09%427.78M | -4.33%2.13B | -9.27%1.54B | 2.07%1.19B | 22.25%639.35M | -1.72%2.23B | -2.66%1.69B | -6.77%1.17B | -26.65%522.97M |
| Staff behalf paid | 14.59%222.52M | 20.32%113.46M | 27.56%371.81M | 32.55%284.07M | 30.91%194.19M | 23.54%94.29M | 35.31%291.48M | 39.87%214.31M | 43.78%148.34M | 40.63%76.33M |
| All taxes paid | 34.17%239.61M | 102.15%194.25M | 5.97%355.51M | 2.81%272.26M | -20.72%178.58M | -12.10%96.09M | 61.23%335.49M | 63.21%264.82M | 103.30%225.26M | 124.30%109.31M |
| Cash paid relating to other operating activities | -26.29%147.3M | -38.57%56.83M | -12.13%553.01M | -34.78%321.33M | -36.82%199.82M | -41.46%92.52M | -1.90%629.35M | 11.34%492.71M | 30.34%316.3M | 14.00%158.04M |
| Cash outflows from operating activities | -12.20%1.55B | -14.09%792.32M | -2.08%3.41B | -9.43%2.41B | -5.02%1.76B | 6.42%922.25M | 4.57%3.48B | 6.71%2.66B | 8.71%1.86B | -9.22%866.65M |
| Net cash flows from operating activities | -3.80%606.44M | 64.15%200.99M | 171.93%1.62B | 85.46%1.17B | 26.42%630.36M | -51.41%122.44M | -12.90%595.45M | 156.89%631.51M | 239.27%498.61M | 3,999.30%252.01M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 20.33%930.93M | 445.07%382.02M | -22.70%1.57B | -37.78%1.48B | -59.74%773.66M | -93.85%70.09M | -45.85%2.04B | -37.33%2.39B | -9.88%1.92B | 13.66%1.14B |
| Cash received from returns on investments | -4,886.79%-15.68M | ---- | -57.08%14.34M | -98.09%958.51K | -99.19%327.52K | -99.96%8.13K | 147.28%33.42M | 205.72%50.25M | 323.28%40.34M | 27,233.42%22.9M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | 36.49%152.92K | -54.15%1.56M | -37.34%758.16K | --874.06K | -79.24%112.04K | --3.4M | --1.21M | ---- |
| Cash inflows from investing activities | 18.14%915.25M | 438.30%382.02M | -23.26%1.59B | -39.04%1.49B | -60.54%774.74M | -93.89%70.97M | -45.16%2.07B | -36.20%2.44B | -8.34%1.96B | 15.93%1.16B |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 216.60%271.2M | 25.67%49.55M | -10.85%419.07M | -45.87%193.2M | -67.79%85.66M | -78.78%39.43M | 6.65%470.08M | 60.85%356.94M | 99.98%265.97M | 154.47%185.83M |
| Cash paid to acquire investments | 179.96%2.04B | 857.67%1.12B | 16.56%2.33B | -49.12%1.5B | -66.93%727.08M | -89.94%117.2M | -36.49%2B | -10.19%2.94B | 12.48%2.2B | 624.02%1.17B |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | --4.59M | ---- | --19.94M | --9.87M | ---- |
| Cash outflows from investing activities | 183.82%2.31B | 626.91%1.17B | 11.34%2.75B | -49.08%1.69B | -67.15%812.74M | -88.07%161.23M | -31.46%2.47B | -5.11%3.32B | 18.53%2.47B | 470.66%1.35B |
| Net cash flows from investing activities | -3,562.11%-1.39B | -775.21%-789.96M | -190.15%-1.16B | 76.92%-202.85M | 92.56%-38M | 52.24%-90.26M | -335.39%-400.5M | -369.49%-878.96M | -1,040.27%-511.03M | -124.68%-188.97M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | -99.09%374.15K | -87.05%5.33M | -87.05%5.33M | ---- |
| Cash from borrowing | 45.04%1.94B | 95.89%1.1B | 1.22%3.4B | -35.88%2.18B | -31.48%1.34B | -9.87%560.38M | 57.91%3.36B | 40.58%3.4B | -1.88%1.95B | -25.47%621.77M |
| Cash inflows from financing activities | 45.04%1.94B | 95.89%1.1B | 1.21%3.4B | -35.99%2.18B | -31.66%1.34B | -9.87%560.38M | 54.93%3.36B | 38.44%3.4B | -3.61%1.96B | -53.43%621.77M |
| Borrowing repayment | -25.57%1.18B | 246.18%604.69M | -10.12%3.09B | 1.22%2.59B | 8.43%1.59B | -60.14%174.67M | 28.00%3.44B | -2.83%2.56B | -9.65%1.47B | -39.98%438.21M |
| Dividend interest payment | -31.75%28.33M | -38.19%11.22M | 9.63%248.47M | 6.64%246.9M | 44.50%41.5M | 57.92%18.16M | 18.20%226.65M | 37.65%231.53M | 57.02%28.72M | -21.33%11.5M |
| Cash payments relating to other financing activities | 135.63%11.94M | ---- | 118.17%8.7M | -97.98%5.1M | 351.63%5.07M | --50M | -98.02%3.99M | --252.54M | --1.12M | ---- |
| Cash outflows from financing activities | -25.23%1.22B | 153.64%615.91M | -8.76%3.35B | -6.60%2.84B | 9.38%1.64B | -46.00%242.83M | 19.13%3.67B | 8.60%3.05B | -8.84%1.49B | -39.87%449.71M |
| Net cash flows from financing activities | 339.67%715.81M | 51.73%481.8M | 116.47%51.2M | -286.42%-666.21M | -164.81%-298.67M | 84.56%317.54M | 65.93%-310.81M | 203.23%357.36M | 18.42%460.82M | -70.70%172.06M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -131.87%-4.31M | -109.63%-236.64K | 616.33%83.18M | -309.72%-59.92M | 14.77%13.51M | 220.37%2.46M | -180.37%-16.11M | 57.11%28.57M | -38.11%11.77M | 15.17%-2.04M |
| Net increase in cash and cash equivalents | -123.94%-73.56M | -130.50%-107.41M | 548.21%591.51M | 74.91%242.22M | -33.24%307.21M | 51.12%352.19M | -242.17%-131.97M | -43.24%138.48M | -24.50%460.17M | -82.82%233.06M |
| Add:Begin period cash and cash equivalents | 195.43%894.19M | 195.43%894.19M | -30.36%302.67M | -30.36%302.67M | -30.36%302.67M | -30.36%302.67M | -8.15%434.65M | -8.15%434.65M | -8.15%434.65M | -9.05%434.65M |
| End period cash equivalent | 34.55%820.62M | 20.14%786.78M | 195.43%894.19M | -4.93%544.89M | -31.84%609.89M | -1.92%654.86M | -30.36%302.67M | -20.09%573.13M | -17.35%894.82M | -63.60%667.71M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- |
| Auditor | -- | -- | Notarized Tianye Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongtianyun Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg